Heart failure is a clinical condition with complex pathophysiology that involves many
different processes. Diagnosis is often difficult in patients presenting for the first time with …

New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

The natriuretic peptides are a family of related hormones that play a crucial role in
cardiovascular homeostasis. They have recently emerged as potentially important clinical …

BACKGROUND: Measurement of circulating natriuretic peptides has been shown to play an
important role in diagnosis and prognosis in patients with chronic heart failure. Whether …

Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

BACKGROUND Heart failure (HF) is a complex syndrome with an enormous societal burden
in terms of cost and morbidity and mortality. Natriuretic peptide (NP) testing is now widely …

Cardiac biomarkers play an important role in heart failure. The family of natriuretic peptides,
especially B-type natriuretic peptide, was identified as a valued diagnostic and prognostic …

The current standard treatment of chronic heart failure (HF) is based on clinical judgment,
with the goal of achieving the maximally tolerated therapeutic program. The complexity of …

Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost,
morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis …

In the past decade there have been many reports on how the assay of natriuretic peptides
might influence the management of patients with heart failure. However, the studies have …